Combined application of targeted therapy and immunotherapy in chronic myeloid leukaemia

Projektinformationen

IMMUNOTHERAPY IN CML

ID Finanzhilfevereinbarung: 224957

Projekt abgeschlossen

Startdatum 3 November 2008

Enddatum 2 November 2012

Finanziert unter

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Gesamtkosten € 100 000,00

EU-Beitrag € 100 000,00

Koordiniert durch

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE
United Kingdom